Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

September 18, 2024

How Are Life Sciences Companies Raising Capital in 2026?

April 19, 2026

Arrowhead and Horizon sign $700M collaboration deal to to Develop RNAi drug for uncontrolled gout

June 25, 2021

Must Read

The New Playbook for Pharmaceutical Growth

June 10, 2026

Top 10 Operational Risks in Modern Clinical Trial Management

June 10, 2026

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

June 10, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck and Gilead Report Phase 3 HIV Success as Lung Cancer Trial Ends

Bial Says Goodbye to Asset Over Phase 2 Parkinson’s Failure

ADC Therapeutics’ Zynlonta Trial Results in Multiple Patient Deaths

Parabilis Plans Phase 3 Desmoid Tumor Trial for Zolucatetide as It Pursues IPO

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

The New Playbook for Pharmaceutical Growth

Top 10 Operational Risks in Modern Clinical Trial Management

Top 10 Challenges Slowing AI Adoption in Drug Discovery

Top 10 Data Governance Challenges Facing Life Sciences Companies

Clinical

A little boy’s tragic cardiac arrest puts Pfizer’s Phase 3 gene therapy experiment on hold

Editor Picks

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

How Are Life Sciences Companies Raising Capital in 2026?

Arrowhead and Horizon sign $700M collaboration deal to to Develop RNAi drug for uncontrolled gout

Must Read

The New Playbook for Pharmaceutical Growth

Top 10 Operational Risks in Modern Clinical Trial Management

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Hot Topics

About Us

Follow Us